12,868
Total Claims
$2.8M
Drug Cost
1,733
Beneficiaries
$1,642
Cost/Patient
Peer Comparison vs. 18,720 Cardiology providers
+8%
Cost per patient vs peers
$1,642 vs $1,524 avg
Opioid Prescribing
0.1%
Opioid Rate
12
Opioid Claims
$69
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
100% generic
Brand: 0 claims · $0
Generic: 9,661 claims · $285K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Sacubitril/Valsartan | 1,541 | $1.3M |
| Apixaban | 535 | $488K |
| Rivaroxaban | 274 | $230K |
| Evolocumab | 178 | $127K |
| Alirocumab | 110 | $80K |
| Dapagliflozin Propanediol | 44 | $51K |
| Ticagrelor | 65 | $45K |
| Empagliflozin | 39 | $36K |
| Evolocumab | 33 | $32K |
| Vericiguat | 29 | $29K |
| Dronedarone Hcl | 20 | $23K |
| Nifedipine | 496 | $21K |
| Nebivolol Hcl | 204 | $21K |
| Icosapent Ethyl | 49 | $19K |
| Losartan Potassium | 677 | $17K |
Prescribing Profile
84
Unique Drugs
$2.1M
Patient Profile
74
Avg Age
55%
Female
2.06
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data